Rheumatoid Arthritis (RA) is a chronic autoimmune disease that causes inflammation and joint damage, affecting mobility and quality of life. When RA doesn’t adequately respond to anti-TNF treatments, Rituxan® (rituximab) in combination with methotrexate may offer another option. Learn more about RA and its effects on the body and how Rituxan may help.
Rituxan is administered as an intravenous infusion in combination with methotrexate as part of your treatment plan. The dosing involves two infusions, which are given two weeks apart every 24 weeks or based on your needs, as determined by your doctor. Read about how Rituxan works and what to expect during your treatment process. Your healthcare provider will give you guidance on preparing for treatment.
Some common side effects of Rituxan include infusion-related reactions, such as fever, chills, or nausea. Discuss treatment outcomes and any potential risks with your doctor to determine the best path for your RA management. If you need assistance, explore our RA support resources and FAQs or find options for financial support.